CN107141281B - 一种左旋艾普拉唑钠化合物及其药物组合物和制备方法 - Google Patents
一种左旋艾普拉唑钠化合物及其药物组合物和制备方法 Download PDFInfo
- Publication number
- CN107141281B CN107141281B CN201710507873.5A CN201710507873A CN107141281B CN 107141281 B CN107141281 B CN 107141281B CN 201710507873 A CN201710507873 A CN 201710507873A CN 107141281 B CN107141281 B CN 107141281B
- Authority
- CN
- China
- Prior art keywords
- sodium
- freeze
- compound
- preparation
- ilaprazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710507873.5A CN107141281B (zh) | 2017-06-28 | 2017-06-28 | 一种左旋艾普拉唑钠化合物及其药物组合物和制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710507873.5A CN107141281B (zh) | 2017-06-28 | 2017-06-28 | 一种左旋艾普拉唑钠化合物及其药物组合物和制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107141281A CN107141281A (zh) | 2017-09-08 |
CN107141281B true CN107141281B (zh) | 2020-04-14 |
Family
ID=59784214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710507873.5A Active CN107141281B (zh) | 2017-06-28 | 2017-06-28 | 一种左旋艾普拉唑钠化合物及其药物组合物和制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107141281B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101098867A (zh) * | 2005-03-25 | 2008-01-02 | 丽珠医药集团股份有限公司 | 取代的亚砜类化合物和其制备方法及用途 |
WO2008083319A1 (en) * | 2006-12-29 | 2008-07-10 | Il Yang Pharmaceutical Company, Ltd. | Solid state forms of enantiopure ilaprazole |
CN105055342A (zh) * | 2015-08-13 | 2015-11-18 | 青岛蓝盛洋医药生物科技有限责任公司 | 一种治疗消化性溃疡的药物艾普拉唑钠组合物冻干粉针剂 |
-
2017
- 2017-06-28 CN CN201710507873.5A patent/CN107141281B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101098867A (zh) * | 2005-03-25 | 2008-01-02 | 丽珠医药集团股份有限公司 | 取代的亚砜类化合物和其制备方法及用途 |
WO2008083319A1 (en) * | 2006-12-29 | 2008-07-10 | Il Yang Pharmaceutical Company, Ltd. | Solid state forms of enantiopure ilaprazole |
CN105055342A (zh) * | 2015-08-13 | 2015-11-18 | 青岛蓝盛洋医药生物科技有限责任公司 | 一种治疗消化性溃疡的药物艾普拉唑钠组合物冻干粉针剂 |
Also Published As
Publication number | Publication date |
---|---|
CN107141281A (zh) | 2017-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105461693B (zh) | Crth2拮抗剂化合物及其用途 | |
EP3466939B1 (en) | New dapagliflozin crystal form and preparation method and use thereof | |
CN104013586A (zh) | 一种注射用兰索拉唑冻干粉针剂的制备工艺 | |
CN104788421B (zh) | 一种治疗呼吸道炎症的厄多司坦化合物及其制备方法 | |
CN107141281B (zh) | 一种左旋艾普拉唑钠化合物及其药物组合物和制备方法 | |
CN107973739A (zh) | 右旋奥拉西坦晶型ii及其制备方法和用途 | |
CN102670524B (zh) | 一种注射用泮托拉唑钠冻干制剂及其制备方法 | |
TW201619129A (zh) | 含吡咯環質子泵抑制劑的半富馬酸鹽及其晶型、中間體和醫藥用途 | |
CN111467344A (zh) | 一种拉西地平固体分散体及其制备方法 | |
CN102488650A (zh) | 一种环磷腺苷药物组合物及其制备方法 | |
CN104072482A (zh) | 一种雷贝拉唑钠化合物及其药物组合物 | |
CN106831709B (zh) | 右旋兰索拉唑-异烟碱共晶及其应用 | |
CN107311984B (zh) | 一种右旋艾普拉唑钠化合物及其药物组合物和制备方法 | |
CN103462909B (zh) | 一种注射用尼扎替丁制剂 | |
CN101491495A (zh) | 丹酚酸b镁注射剂、制备方法及应用 | |
JP2006508968A (ja) | ウルソル酸−大豆レシチン凍結乾燥ナノ粒子注射剤およびその製造方法 | |
CN103494778B (zh) | 一种埃索美拉唑钠冻干制剂及其制备方法 | |
CN105395490B (zh) | 一种含右旋雷贝拉唑钠药物组合物冻干粉针及其制备方法 | |
CN110314143A (zh) | 注射用右旋奥拉西坦冻干制剂及其制备方法 | |
CN103772359B (zh) | 一种兰索拉唑化合物 | |
CN105949081B (zh) | 一种沙芬酰胺甲磺酸盐新晶型及其制备方法 | |
KR950015059B1 (ko) | 오메프라졸의 신규 경구용 약제 | |
CN105055442A (zh) | 一种治疗胃病的药物盐酸雷尼替丁组合物 | |
KR20230114163A (ko) | 칼륨 경쟁적 위산분비억제제 계열 약물의 신규한 무정형 고체분산체 및 그의 제조방법 | |
CN104257607A (zh) | 一种紫杉醇注射液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 519015 west side of the second floor of Everbright International Trade Center, 47 Haibin South Road, Jida, Zhuhai City, Guangdong Province Patentee after: Sailong Pharmaceutical Group Co.,Ltd. Address before: 519015 west side of 2nd floor, Everbright International Trade Center, No. 47, Jida Haibin South Road, Xiangzhou District, Zhuhai City, Guangdong Province Patentee before: ZHUHAI SAILONG PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211222 Address after: 410100 No. 1, Hongfeng Road, Xingsha industrial base (Changlong Street), Changsha Economic and Technological Development Zone, Hunan Province Patentee after: Hunan Sailong Pharmaceutical (Changsha) Co.,Ltd. Address before: 519015 west side of the second floor of Everbright International Trade Center, 47 Haibin South Road, Jida, Zhuhai City, Guangdong Province Patentee before: Sailong Pharmaceutical Group Co.,Ltd. |